Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression.
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.
The origins of multiple sclerosis: a synthesis
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Ibuprofen-induced unilateral optic neuritis.
Brain imaging and bladder function.
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
Heat shock protein 27 in multiple sclerosis relapses.
Compassionate Use Programme Update
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Multiple sclerosis and glutamate excitotoxicity.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Pages